PROCR and cancer: The recent review article by Marek Z. Wojtukiewicz and co-workers [3] provides a comprehensive overview of the impact of endothelial protein C receptor (EPCR; CD201) and protease-activated receptor-1 (PAR-1), traditionally related to the blood coagulation cascade, on cancer growth and metastasis.